U.S. regulator grants full approval to the Pfizer vaccine. It’s the first to get such a clearance. But not everyone agrees with the decision. What are the concerns? Business growth slowing in July as supply chain problems persist and demand cools off. We talk to an American manufacturer. And two vital money-transfer firms have stopped all services in Afghanistan, as financial institutions worry about accidentally giving the Taliban any money.
Read More
RSS Feed | The Epoch Times
